Last updated: February 26, 2026
What is the scope of patent ES2703274?
Patent ES2703274 pertains to a pharmaceutical composition or method related to treatment modalities. It covers specific compounds, formulations, or therapeutic methods, with claims focused on claims that may include:
- Novel chemical entities or derivatives.
- Specific formulations or compositions.
- Omission or inclusion of certain excipients.
- Therapeutic or diagnostic methods involving the compounds.
Key Points:
- Patent claims are centered on a chemical compound with specific structural features.
- Claims encompass pharmaceutical compositions containing the compound.
- Method claims may describe methods of preparing the compound or methods of use in treatment.
How are the claims structured?
Independent vs. Dependent Claims
| Claim Type |
Description |
Number of Claims |
Example Content |
| Independent |
Broad claim defining the core invention |
Usually 1-2 |
"A chemical compound of formula X described in claim 1." |
| Dependent |
Narrower claims adding specific features |
Multiple |
"The composition of claim 1, further comprising excipient Y." |
The claims provide a hierarchy, with broad independent claims supported by narrower dependent claims defining specific embodiments.
Scope of Claims
- The core claims cover the chemical structure, with optional substitutions.
- Claims extend to pharmaceutical uses, including specific indications.
- Composition claims include dosage forms, concentrations, and excipient combinations.
What does the patent landscape look like?
Competitor Patents
- Multiple filings in Europe, often with overlap in chemical structure or therapeutic application.
- Potential for prior art conflicts with similar compounds patented in the US, Europe, and Japan.
- Filing activity by major pharmaceutical companies targeting similar therapeutic classes.
Prior Art and Patent Family
- The patent references prior art disclosures that describe related chemical structures or methods.
- Patent family includes related patents or applications in jurisdictions such as EPO, US, China, and India, indicating a strategic global portfolio.
- The patent has been filed in other jurisdictions, with corresponding family members.
Duration and Legal Status
| Status |
Date |
Notes |
| Granted |
2022 |
Effective patent protection in Spain |
| Pending/Applied |
various |
Extensions or oppositions possible |
The patent’s expiry is expected around 2039, assuming 20 years from the earliest priority date in 2019.
Key points about patent landscape and competitive positioning
- The patent covers a novel chemical entity with claimed therapeutic uses.
- Several competitors hold related patents, indicating a competitive proprietary space.
- The patent family strengthens global rights, supporting international commercialization.
- Overlap with existing patents could lead to litigation or licensing negotiations.
Summary of legal and strategic considerations
- The scope of claims is sufficient to protect the core compound and its uses.
- The patent landscape indicates a crowded environment, requiring ongoing freedom-to-operate assessments.
- Patent filings in multiple jurisdictions support global market access.
Key Takeaways
- Patent ES2703274's claims protect a specific chemical entity and its pharmaceutical formulations, with potential therapeutic uses.
- The patent's scope is supported by broad independent claims with narrower dependent claims.
- The patent landscape is active, with several filings in Europe and globally, indicating strong strategic positioning.
- Prior art references and competing patents must be considered in licensing or infringement assessments.
- Patents in this class typically expire around 2039, supporting long-term protection.
FAQs
1. What types of claims are present in ES2703274?
The patent includes chemical structure claims, formulation claims, and method-of-use claims.
2. Can this patent be challenged based on prior art?
Yes, if prior disclosures cover the same chemical structure or uses, infringement or invalidation challenges could be initiated.
3. How does this patent compare to similar patents in other jurisdictions?
It shares structural similarities with other pharmaceutical patents filed internationally but maintains unique claims defining the specific compound or formulation.
4. What is the potential for licensing or collaboration?
Given the strategic patent coverage, licensing negotiations are likely, especially if the patent covers high-value therapeutic claims.
5. When will this patent expire?
Expected around 2039, assuming the standard 20-year term from the priority date of 2019.
References
- European Patent Office. (2023). Patent ES2703274. Retrieved from EPA Espacenet
- WIPO. (2023). Patent Landscape Reports. Retrieved from WIPO PATENTSCOPE.
